TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34908227

Group type: EXPERIMENTAL
Intervention: Lipid-based peanut paste
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Biscuit
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 34147150

Group type: EXPERIMENTAL
Intervention: Obeticholic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32723163

Group type: EXPERIMENTAL
Intervention: Falls in the past year
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Previous falls
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Accidental falls
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Time of falls
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Season of falls
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Falling flat on the ground
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Fall location
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Presence of an object favoring the fall
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Floor conditions
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Type of footwear
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Need for assistance to get up
Number of subjects: 966
Study: 34536308

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with carfilzomib (27-56 mg/sqm) and dexamethasone (20 mg every second week)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 200
Study: 33662112

Group type: EXPERIMENTAL
Intervention: Overminus spectacle therapy (‐2.50 D for 12 months, then ‐1.25 D for 3 months, followed by nonoverminus spectacles for 3 months)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Nonoverminus spectacle use
Number of subjects: 386
Study: 33321842

Group type: EXPERIMENTAL
Intervention: EC-based alignment using a motion detection based approach with cascaded regression of extremely randomized trees.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Annotator disagreement in face pose alignment.
Number of subjects: 0
Study: 34420187

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 32418064

Group type: EXPERIMENTAL
Intervention: Hypnosis-induced hallucinated breakfast (HB)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Real breakfast (RB)
Number of subjects: 8
Study: 35710428

Group type: EXPERIMENTAL
Intervention: Diabetes mobile application
Number of subjects: 180

Group type: COMPARATOR
Intervention: Current standard care
Number of subjects: 180
Study: 35467300

Group type: EXPERIMENTAL
Intervention: ω‐3 fatty acid immunonutritional therapy
Number of subjects: 70
Study: 33939973

Group type: EXPERIMENTAL
Intervention: Supervised physical exercise twice a week
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 121
Study: 32820744

Group type: EXPERIMENTAL
Intervention: Access to audiology services
Number of subjects: 6432

Group type: EXPERIMENTAL
Intervention: Hearing loss
Number of subjects: 6432
Study: 33724668

Group type: EXPERIMENTAL
Intervention: Loop-tail stents (Polaris™ Loop)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional double J stents (Vortek®)
Number of subjects: 68
Study: 34538755

Group type: EXPERIMENTAL
Intervention: Acebilustat 50 mg
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Acebilustat 100 mg
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Acebilustat (both doses)
Number of subjects: 199
Study: 35513562

Group type: EXPERIMENTAL
Intervention: Smartphone electrocardiogram (AliveCor Kardia) used 5 times/week
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 100
Study: 35130231

Group type: EXPERIMENTAL
Intervention: Otoscopic findings
Number of subjects: 203

Group type: COMPARATOR
Intervention: Tympanometric impedance measurement
Number of subjects: 203
Study: 34260519

Group type: EXPERIMENTAL
Intervention: Jinfukang
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 33066773

Group type: EXPERIMENTAL
Intervention: Family-centered behavioral and educational counselling program
Number of subjects: 589

Group type: COMPARATOR
Intervention: OHE pamphlets (control group)
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 589
Study: 34145078

Group type: EXPERIMENTAL
Intervention: Health check programme (IG)
Number of subjects: 10505
Study: 33330983

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 69

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 69
Study: 32865373

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg monthly subcutaneous injections)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157

Group type: COMPARATOR
Intervention: Evolocumab and Placebo
Number of subjects: 157
Study: 34551415

Group type: EXPERIMENTAL
Intervention: Active left rTMS
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Active right rTMS
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 46
Study: 33617942

Group type: EXPERIMENTAL
Intervention: Glass Hybrid (GH) - EQUIA Forte, GC
Number of subjects: 180

Group type: COMPARATOR
Intervention: Composite (CO) - TetricEvoCeram, IvoclarVivadent
Number of subjects: 180
Study: 32303373

Group type: EXPERIMENTAL
Intervention: Hand sanitizer group (HSG); n=339
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Soap and water group; n=274
Number of subjects: 911

Group type: COMPARATOR
Intervention: Control group (CG); n=298
Number of subjects: 911
Study: 32460658

Group type: EXPERIMENTAL
Intervention: Victimization salience: yes (reminded of a previous victimization experience)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Victimization salience: no (not reminded of a previous victimization experience)
Number of subjects: 181
Study: 32511829

Group type: EXPERIMENTAL
Intervention: Passive Movement (PM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Passive Movement + Blood Flow Restriction (PM + BFR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Time Control (TC)
Number of subjects: 20
Study: 36113007

Group type: EXPERIMENTAL
Intervention: Compound betamethasone
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no compound betamethasone)
Number of subjects: 38
Study: 34036457

Group type: EXPERIMENTAL
Intervention: Infertility labeled as 'disease'
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Infertility labeled as 'disability'
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Infertility labeled as 'condition'
Number of subjects: 1226
Study: 34176610

Group type: EXPERIMENTAL
Intervention: Action stage
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Maintenance stage (parents)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Action stage (parents)
Number of subjects: 98
Study: 34057298

Group type: EXPERIMENTAL
Intervention: Shoe-stiffening inserts
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham inserts
Number of subjects: 48

Group type: COMPARATOR
Intervention: Shoe only (control)
Number of subjects: 48
Study: 34255009

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injection
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 240
Study: 36121729

Group type: EXPERIMENTAL
Intervention: Novel polymeric nanoparticle gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: Commercial gel (Opalescence PF)
Number of subjects: 80
Study: 32820846

Group type: EXPERIMENTAL
Intervention: WT - whitening toothpaste
Number of subjects: 75

Group type: COMPARATOR
Intervention: CT - conventional toothpaste
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CP10 - 10% carbamide peroxide
Number of subjects: 75
Study: 34488379

Group type: EXPERIMENTAL
Intervention: Multi-component exercise training
Number of subjects: 90

Group type: COMPARATOR
Intervention: General community health instruction
Number of subjects: 90
Study: 34312883

Group type: EXPERIMENTAL
Intervention: Fostering Healthy Futures program (FHF), a 9-month one-to-one mentoring and skills group intervention
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Fostering Healthy Futures program (FHF)
Number of subjects: 426
Study: 34546534

Group type: EXPERIMENTAL
Intervention: AZD5718 (60 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AZD5718 (180 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AZD5718 (360 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AZD5718 (600 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 34751888

Group type: EXPERIMENTAL
Intervention: Nuestras Familias: Andando Entre Culturas (culturally adapted evidence-based parent management training)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 241
Study: 34493958

Group type: EXPERIMENTAL
Intervention: HIIT protocol 4×4
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HIIT protocol 10-20-30
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HIIT protocol 6×1
Number of subjects: 10
Study: 36440782

Group type: EXPERIMENTAL
Intervention: Relatox injections
Number of subjects: 180

Group type: COMPARATOR
Intervention: Botox injections
Number of subjects: 180

Group type: COMPARATOR
Intervention: Relatox and Botox (both groups)
Number of subjects: 180
Study: 33805025

Group type: EXPERIMENTAL
Intervention: Active play intervention (≥2 children jumping together for approximately 10 s per session, at least five times a day, approximately 1 min/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 36060670

Group type: EXPERIMENTAL
Intervention: Integrated medical and nursing rounds combined with AIDET communication mode
Number of subjects: 60

Group type: COMPARATOR
Intervention: Integrated medical and nursing rounds
Number of subjects: 60
Study: 34627875

Group type: EXPERIMENTAL
Intervention: Duodenal mucosal resurfacing (DMR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham endoscopy
Number of subjects: 32
Study: 36059130

Group type: COMPARATOR
Intervention: Rilpivirine-based ART
Number of subjects: 0

Group type: COMPARATOR
Intervention: Darunavir-based ART
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etonogestrel and Levonorgestrel implants
Number of subjects: 0
Study: 34386816

Group type: EXPERIMENTAL
Intervention: Vegetable Intervention (VI) - participants received extra vegetables (≥270 g/d)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Attention Control (CON) - conducted only the testing visits
Number of subjects: 102
Study: 35284550

Group type: EXPERIMENTAL
Intervention: Defect management improvement mode based on the JCI standard
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standardized management mode
Number of subjects: 32
Study: 32393405

Group type: EXPERIMENTAL
Intervention: Experimental condition (reading a scientific abstract on the importance of thought control)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control condition (reading a neutral abstract)
Number of subjects: 85
Study: 35960009

Group type: EXPERIMENTAL
Intervention: Robot-assisted modified radical hysterectomy with removal of lymphatic vessels (RLV) using indocyanine green (ICG)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Robot-assisted modified radical hysterectomy without removal of lymphatic vessels (RLV)
Number of subjects: 34
Study: 34747338

Group type: EXPERIMENTAL
Intervention: Allogenic fecal microbiota transplant (FMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant (FMT)
Number of subjects: 0
Study: 35080598

Group type: COMPARATOR
Intervention: Taper to placebo (taper group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Continue SRI (continuation group)
Number of subjects: 101
Study: 34302145

Group type: EXPERIMENTAL
Intervention: Drug repositioning approaches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Common variant genetics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcriptome-wide association studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gene-set association
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal inference by Mendelian randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polygenic scoring
Number of subjects: 0
Study: 32573782

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 64
Study: 35363627

Group type: EXPERIMENTAL
Intervention: Erlotinib 100 mg/d
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Erlotinib 50 mg/d
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 33564986

Group type: EXPERIMENTAL
Intervention: Severe/very severe pain
Number of subjects: 2310

Group type: COMPARATOR
Intervention: No pain
Number of subjects: 2310

Group type: EXPERIMENTAL
Intervention: Pain severity (general)
Number of subjects: 2310
Study: 32853116

Group type: COMPARATOR
Intervention: Muscle-directed stretching
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nerve-directed stretching
Number of subjects: 60
Study: 35263519

Group type: EXPERIMENTAL
Intervention: Ribociclib plus letrozole
Number of subjects: 668

Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 668
Study: 32234739

Group type: EXPERIMENTAL
Intervention: CytoSorb haemoadsorber
Number of subjects: 25
Study: 35616594

Group type: EXPERIMENTAL
Intervention: LPS administration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32554514

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg plus nab‐paclitaxel 125 mg/m2 and gemcitabine 1,000 mg/m2
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nivolumab plus nab‐paclitaxel and gemcitabine
Number of subjects: 50
Study: 33678201

Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplements (ONS)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Routine Care (Control)
Number of subjects: 409
Study: 33773565

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system plus metformin (500mg twice daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Levonorgestrel intrauterine system only
Number of subjects: 51
Study: 32135005

Group type: EXPERIMENTAL
Intervention: Singing and dancing
Number of subjects: 21

Group type: COMPARATOR
Intervention: Dancing only
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Maximal aerobic capacity test
Number of subjects: 21
Study: 36213713

Group type: EXPERIMENTAL
Intervention: Provision of information and supportive nursing care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no provision of information and supportive nursing care)
Number of subjects: 60
Study: 33862407

Group type: EXPERIMENTAL
Intervention: VR-ABM
Number of subjects: 108

Group type: COMPARATOR
Intervention: VR-control
Number of subjects: 108
Study: 33574155

Group type: EXPERIMENTAL
Intervention: Intravenous acellular sterile filtered amniotic fluid
Number of subjects: 100
Study: 32020170

Group type: EXPERIMENTAL
Intervention: Puregraft fat and 0.5 × 10^6 ADRCs/cm2 scalp
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Puregraft fat and 1.0 × 10^6 ADRCs/cm2 scalp
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Puregraft fat alone
Number of subjects: 71

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 71
Study: 35347394

Group type: EXPERIMENTAL
Intervention: Hypocaloric legume-based DASH diet
Number of subjects: 300

Group type: COMPARATOR
Intervention: Hypocaloric DASH diet
Number of subjects: 300
Study: 34932772

Group type: EXPERIMENTAL
Intervention: Auriculotherapy (AT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 36
Study: 35040600

Group type: EXPERIMENTAL
Intervention: Adalimumab (5 mg/kg) administered intraperitoneally for 4 weeks
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 4
Study: 32128971

Group type: EXPERIMENTAL
Intervention: Post-transplant exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 0
Study: 36106542

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 162 mg every week for 24 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 34127039

Group type: EXPERIMENTAL
Intervention: Seated lumbar rotation manipulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lumbar traction in supine position
Number of subjects: 60
Study: 32505770

Group type: EXPERIMENTAL
Intervention: Diagnostic model for lung cancer based on platelet features
Number of subjects: 245

Group type: COMPARATOR
Intervention: Diagnostic model for lung cancer
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Diagnostic model for colon cancer based on platelet features
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Diagnostic model for differentiating lung malignancy from benign diseases
Number of subjects: 245
Study: 36307602

Group type: EXPERIMENTAL
Intervention: Single-incision distal gastrectomy (SIDG)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Multiport laparoscopic distal gastrectomy (MLDG)
Number of subjects: 83
Study: 33389280

Group type: EXPERIMENTAL
Intervention: Biofeedback device group
Number of subjects: 34

Group type: COMPARATOR
Intervention: Self-directed breathing exercise group
Number of subjects: 34

Group type: COMPARATOR
Intervention: Psychoeducation group
Number of subjects: 34
Study: 35775513

Group type: EXPERIMENTAL
Intervention: Steri-Strips™
Number of subjects: 75

Group type: COMPARATOR
Intervention: Subcuticular suturing
Number of subjects: 75
Study: 34586931

Group type: EXPERIMENTAL
Intervention: Prognostic nomogram based on SOFA
Number of subjects: 5240

Group type: COMPARATOR
Intervention: SOFA model
Number of subjects: 5240
Study: 32830635

Group type: EXPERIMENTAL
Intervention: Xenon light source
Number of subjects: 64

Group type: COMPARATOR
Intervention: Light-emitting diode
Number of subjects: 64
Study: 34080304

Group type: EXPERIMENTAL
Intervention: SBC-based nursing intervention
Number of subjects: 82
Study: 33773969

Group type: EXPERIMENTAL
Intervention: Artificial intelligence model using chest x-rays and clinical data for severity prediction
Number of subjects: 1834

Group type: EXPERIMENTAL
Intervention: Deep-learning features combined with clinical data for progression prediction
Number of subjects: 1834

Group type: EXPERIMENTAL
Intervention: Combined image and clinical data model
Number of subjects: 1834
Study: 35279917

Group type: EXPERIMENTAL
Intervention: Unpleasant olfactory and gustatory stimuli
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pleasant and neutral stimuli
Number of subjects: 22
Study: 34319510

Group type: EXPERIMENTAL
Intervention: UC-MSC treatment (1-2 × 10^6 per kilogram)
Number of subjects: 210
Study: 32295417

Group type: EXPERIMENTAL
Intervention: Colchicine 1.8 mg
Number of subjects: 714
Study: 36351563

Group type: EXPERIMENTAL
Intervention: aPDT (methylene blue-mediated)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Chlorhexidine gargle
Number of subjects: 83

Group type: COMPARATOR
Intervention: Normal saline rinse
Number of subjects: 83
Study: 34610135

Group type: EXPERIMENTAL
Intervention: mOPV2
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: nOPV2-c1
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: nOPV2-c2
Number of subjects: 621
Study: 33130935

Group type: EXPERIMENTAL
Intervention: Single-loaded single-row technique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Double-loaded single-row technique
Number of subjects: 50
Study: 35004547

Group type: EXPERIMENTAL
Intervention: Online self-control training added to multidisciplinary obesity treatment (MOT) program
Number of subjects: 259

Group type: COMPARATOR
Intervention: Sham training added to multidisciplinary obesity treatment (MOT) program
Number of subjects: 259
Study: 35863864

Group type: EXPERIMENTAL
Intervention: Baseline dactylitis (LDI>0)
Number of subjects: 851

Group type: EXPERIMENTAL
Intervention: Baseline nail disease (mNAPSI >1)
Number of subjects: 851

Group type: COMPARATOR
Intervention: Baseline enthesitis (SPARCC EI>0 or LEI>0)
Number of subjects: 851
Study: 34308545

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention (88 individual sessions, 45 minutes each, twice per week)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 82
Study: 35324509

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia
Number of subjects: 112

Group type: COMPARATOR
Intervention: HF self-management education (attention control)
Number of subjects: 112
Study: 33651291

Group type: EXPERIMENTAL
Intervention: Mycorrhizal treatments (Funneliformis mosseae and Claroideoglomus etunicatum)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (no mycorrhiza)
Number of subjects: 3
Study: 32738465

Group type: EXPERIMENTAL
Intervention: HypoRT with ADT (60 Gy/20 fractions to prostate, 44 Gy to nodal areas)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: HypoRT with ADT
Number of subjects: 105
Study: 34247160

Group type: EXPERIMENTAL
Intervention: Oral frailty measures program (12 weeks)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 83
Study: 616280550

Group type: EXPERIMENTAL
Intervention: NRB (non-rebreather mask) with flush rate oxygen (>40 L/min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BVM (bag-valve-mask) with flush rate oxygen
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BVM with simulated mask leak
Number of subjects: 30

Group type: COMPARATOR
Intervention: NRB vs BVM
Number of subjects: 30
Study: 34210841

Group type: EXPERIMENTAL
Intervention: Universal screening for depression in adolescents
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Assessment as usual
Number of subjects: 10000
Study: 34024526

Group type: EXPERIMENTAL
Intervention: Individual energy supply based on indirect calorimetry (IC group, n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard energy supply based on a formula (SC group, n = 11)
Number of subjects: 20
Study: 33124984

Group type: EXPERIMENTAL
Intervention: Thought Spot app
Number of subjects: 481

Group type: COMPARATOR
Intervention: Usual care (mental health services information pamphlet)
Number of subjects: 481
Study: 36273223

Group type: EXPERIMENTAL
Intervention: VR entertainment 3 times per week during inpatient rehabilitation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30